BioAmber Inc.
BIOA
BIOA was delisted on the 8th of February, 2018.
39 hedge funds and large institutions have $50.2M invested in BioAmber Inc. in 2017 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 12 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
42% more capital invested
Capital invested by funds: $35.3M → $50.2M (+$14.8M)
27% more call options, than puts
Call options by funds: $65K | Put options by funds: $51K
11% more funds holding
Funds holding: 35 → 39 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
58% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$4.7M |
| 2 |
NIPH
NN Investment Partners Holdings
The Hague,
Netherlands
|
+$4.06M |
| 3 |
TD Asset Management
Toronto,
Ontario, Canada
|
+$875K |
| 4 |
Bank of New York Mellon
New York
|
+$95.8K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$62.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$78K |
| 2 |
RS
Robeco Schweiz
Zurich,
Switzerland
|
-$39.1K |
| 3 |
SC
Scotia Capital
Toronto,
Ontario, Canada
|
-$35K |
| 4 |
BlackRock
New York
|
-$31.3K |
| 5 |
Millennium Management
New York
|
-$27K |
BIOA Hedge Fund Activity: Q2 2017 in Review
39 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in BioAmber Inc. (BIOA) for Q2 2017, worth a combined $50.2M — up 42% from $35.3M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new BIOA positions and 3 closed out — a net gain of 4 holders — while 5 added to existing stakes and 12 trimmed.
The largest buyer was Connor, Clark & Lunn Investment Management (CC&L), opening a new position worth an estimated $4.7M. The largest seller was Sabby Management, cutting an estimated $78K.
- 39 institutional investors held BioAmber Inc. (BIOA) as of Q2 2017, up from 35 in Q1 2017.
- Funds reported $50.2M of BioAmber Inc. stock for Q2 2017, up 42% quarter-over-quarter.
- 7 funds opened new BioAmber Inc. positions in Q2 2017 and 3 closed out, a net change of +4 holders.
- The largest BioAmber Inc. buyer in Q2 2017 was Connor, Clark & Lunn Investment Management (CC&L), an estimated $4.7M added.
- The largest BioAmber Inc. seller in Q2 2017 was Sabby Management, an estimated $78K sold.
Based on aggregated 13F filings for Q2 2017.